scispace - formally typeset
T

Thomas J. Giordano

Researcher at University of Michigan

Publications -  261
Citations -  38242

Thomas J. Giordano is an academic researcher from University of Michigan. The author has contributed to research in topics: Cancer & Adenocarcinoma. The author has an hindex of 79, co-authored 249 publications receiving 32645 citations. Previous affiliations of Thomas J. Giordano include University of Colorado Denver & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Somatic mutations affect key pathways in lung adenocarcinoma

Li Ding, +96 more
- 23 Oct 2008 - 
TL;DR: Somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B are found.
Journal ArticleDOI

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal, +242 more
- 23 Oct 2014 - 
TL;DR: The genomic landscape of 496 PTCs is described and a reclassification of thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties is proposed, which has the potential to improve their pathological classification and better inform the management of the disease.
Journal ArticleDOI

Gene-expression profiles predict survival of patients with lung adenocarcinoma

TL;DR: The identification of a set of genes that predict survival in early-stage lung adenocarcinoma allows delineation of a high-risk group that may benefit from adjuvant therapy.
Journal ArticleDOI

Oncogenic Signaling Pathways in The Cancer Genome Atlas

TL;DR: This work charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity.
Journal ArticleDOI

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally, +235 more
- 15 Jun 2017 - 
TL;DR: Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts and development of a p53 target gene expression signature correlating with poor survival was enabled.